Global X Management Company’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$103K Buy
51
+23
+82% +$52.4K ﹤0.01% 1004
2018
Q1
$62K Buy
28
+7
+33% +$17.8K ﹤0.01% 992
2017
Q4
$49K Buy
21
+5
+31% +$10.2K ﹤0.01% 921
2017
Q3
$29K Buy
16
+2
+14% +$2.79K ﹤0.01% 998
2017
Q2
$19K Buy
14
+7
+100% +$8.45K ﹤0.01% 1156
2017
Q1
$9K Hold
7
﹤0.01% 1155
2016
Q4
$6K Hold
7
﹤0.01% 1048
2016
Q3
$6K Hold
7
﹤0.01% 1047
2016
Q2
$4K Buy
+7
New +$3.96K ﹤0.01% 948

Other funds holding BLUE

Global X Management Company's BLUE Position: Q2 2018 in Review

Global X Management Company increased its bluebird bio (BLUE) stake by 82% in Q2 2018, buying an estimated $52.4K and bringing the position to 51 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #1004.

Global X Management Company first reported a position in BLUE in Q2 2016 and has held it in 9 quarters since. 307 funds tracked by Wall St. Rank hold BLUE as of Q2 2018.

  • Global X Management Company held 51 shares of bluebird bio worth $103K as of Q2 2018.
  • Global X Management Company bought 23 bluebird bio shares in Q2 2018, an estimated $52.4K.
  • bluebird bio made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #1004 holding.
  • Global X Management Company first reported a position in bluebird bio in Q2 2016 and has held it in 9 quarters since.
  • 307 funds tracked by Wall St. Rank held bluebird bio as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.